Global Mouse Models Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Mouse Models Market was valued at USD 1.89 billion in 2023 and is projected to reach USD 3.74 billion by 2031, growing at a CAGR of 8.9% during the forecast period from 2023 to 2031. Mouse models are critical tools in biomedical research, enabling scientists to understand disease mechanisms, test drug efficacy, and evaluate toxicity. The market is witnessing significant growth due to increased R&D expenditure in pharmaceutical and biotechnology sectors, the rising prevalence of chronic diseases, and advancements in genetic engineering technologies that enhance the utility of transgenic and knockout models.

Drivers:

1. Rising Investments in Biomedical Research:

Pharmaceutical and biotech companies are increasing their investments in R&D to develop novel therapeutics. Mouse models offer a vital platform for preclinical testing, thereby fueling demand across the research community.

2. Growing Prevalence of Chronic Diseases:

The rise in cancer, cardiovascular disorders, and neurodegenerative diseases such as Alzheimer's and Parkinson's has led to increased utilization of genetically engineered mouse models for studying disease pathology and drug discovery.

3. Advancements in Genetic Engineering:

Technological progress such as CRISPR-Cas9 has revolutionized the development of customized mouse models, enabling faster and more accurate gene editing, which accelerates the creation of disease-specific models.

Restraints:

1. Ethical and Regulatory Concerns:

The use of animals in research is subject to strict ethical regulations. Increasing scrutiny from animal rights organizations and tightening guidelines can hinder market expansion.

2. High Cost of Maintenance and Development:

Developing and maintaining specialized mouse models is expensive, involving sophisticated breeding facilities and extensive vetting processes, which may deter smaller research institutes from widespread adoption.

Opportunity:

1. Expansion of Personalized Medicine:

Mouse avatars, or patient-derived xenograft models, are gaining traction in personalized medicine by predicting individual patient responses to therapies, creating new growth avenues.

2. Rising Demand in Emerging Economies:

Countries in Asia-Pacific and Latin America are ramping up healthcare R&D infrastructure. The growing scientific community in these regions is driving demand for cost-effective and versatile animal models for disease study.

Market by System Type Insights:

The knockout mouse model segment held the largest share in 2023 due to its widespread application in functional genomics and disease modeling. These models allow researchers to study gene deletion effects, making them valuable in understanding disease development. The transgenic mouse models segment is projected to grow at the fastest pace, driven by increased demand for models with humanized genes and the adoption of precision medicine research.

Market by End-use Insights:

The pharmaceutical and biotechnology companies segment dominated the market in 2023, accounting for more than 45% of revenue. These companies heavily rely on mouse models for drug screening, toxicology testing, and efficacy studies. Academic & research institutions also represent a key segment due to government-funded projects and increased collaborations with private firms to advance preclinical studies.

Market by Regional Insights:

North America led the global market in 2023, owing to advanced healthcare infrastructure, high R&D spending, and the presence of major industry players. Asia-Pacific is anticipated to witness the highest growth through 2031, supported by rising investments in life sciences, increasing disease burden, and supportive government initiatives in countries like China and India.

Competitive Scenario:

Key players in the Global Mouse Models Market include The Jackson Laboratory, Charles River Laboratories, Taconic Biosciences, Inc., GenOway S.A., Envigo, Trans Genic Inc., Horizon Discovery Group plc, and Crown Bioscience Inc. These companies are focusing on expanding their genetically modified model portfolios, strategic mergers, and facility expansion to address growing global demand.

Key Developments:

In 2024, Charles River Laboratories introduced a new line of CRISPR-engineered mouse models tailored for oncology research.

The Jackson Laboratory launched a digital repository of patient-derived xenograft models to accelerate cancer drug discovery in 2023.

Taconic Biosciences expanded its footprint in Asia by opening a new breeding facility in Singapore in early 2025.

Scope of Work – Global Mouse Models Market

Report Metric Details

Market Size (2023) USD 1.89 billion

Projected Market Size (2031) USD 3.74 billion

CAGR (2023–2031) 8.9%

Market Segments By System Type (Knockout, Transgenic, etc.), By End-Use (Pharma & Biotech, Academic, CROs), By Region

Growth Drivers Increased R&D Spending, Chronic Disease Burden, Genetic Engineering Advancements

Opportunities Personalized Medicine, Emerging Market Demand

FAQs:

1. What is the current market size of the Global Mouse Models Market?

The Global Mouse Models Market was valued at USD 1.89 billion in 2023.

2. What is the major growth driver of the Global Mouse Models Market?

The major growth driver is the increasing investment in pharmaceutical R&D and the growing application of genetically engineered mouse models in disease research.

3. Which is the largest region during the forecast period in the Global Mouse Models Market?

North America holds the largest market share, driven by high R&D expenditure and established research institutions.

4. Which segment accounted for the largest market share in the Global Mouse Models Market?

The knockout mouse model segment accounted for the largest share due to its extensive application in gene function studies.

5. Who are the key market players in the Global Mouse Models Market?

Key players include The Jackson Laboratory, Charles River Laboratories, Taconic Biosciences, GenOway, and Envigo.